Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up

Atherosclerosis

Volumn 246, Issue , 2016, Pages 208-213

  Fracanzani, Anna Ludovica ^a   Tiraboschi, Silvia ^a   Pisano, Giuseppina ^a   Consonni, Dario ^a   Baragetti, Andrea ^a   Bertelli, Cristina ^a   Norata, Danilo ^a   Valenti, Luca ^a   Grigore, Liliana ^b   Porzio, Marianna ^a   Catapano, Alberico ^a   Fargion, Silvia ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Bassini Hospital   (Italy)

Author keywords

Cardiovascular events; Carotid plaques; Intima media thickness; NAFLD; NASH

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CAROTID ARTERY INJURY; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE COURSE; FATTY LIVER; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INCIDENCE; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; AGED; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASES; CAROTID ARTERY; CAROTID ARTERY DISEASES; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; DIAGNOSTIC IMAGING; ITALY; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; ODDS RATIO; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR;

ADULT; AGED; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; ITALY; KAPLAN-MEIER ESTIMATE; LINEAR MODELS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; ODDS RATIO; PLAQUE, ATHEROSCLEROTIC; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84955487817     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.01.016     Document Type: Article

References (47)

1. Yki-Jarvinen H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol. 2014, 2:901-910.
2. Ekstedt M., Franzén L.E., Mathiesen U.L., et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006, 44(4):865-873.
3. Bhatia L.S., Curzen N.P., Calder P.C., Byrne C.D. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?. Eur. Heart J. 2012, 33(10):1190-1200.
4. Francque S.M. The role of non-alcoholic fatty liver disease in cardiovascular disease. Eur. Cardiol. Rev. 2014, 9:10-15.
5. Pacana T., Fuchs M. The cardiovascular link to nonalcoholic fatty liver disease: a critical analysis. Clin. Liver Dis. 2012, 16(3):599-613.
6. Lu H., Liu H., Hu F., Zou L., Luo S., Sun L. Independent association between nonalcoholic fatty liver disease and cardiovascular disease: a systematic review and meta-analysis. Int. J. Endocrinol. 2013, 2013:124958.
7. Dyson J., Jaques B., Chattopadyhay D., et al. Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team. J. Hepatol. 2014, 60:110-117.
8. Targher G., Day C.P., Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N. Engl. J. Med. 2010, 363(14):1341-1350.
9. Sookoian S., Pirola C.J. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J. Hepatol. 2008, 49(4):600-607.
10. Oni E.T., Agatston A.S., Blaha M.J., et al. A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?. Atherosclerosis 2013, 230(2):258-267.
11. VanWagner L.B., Ning H., Lewis C.E., et al. Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the coronary artery risk development in young adults study. Atherosclerosis 2014, 235(2):599-605.
12. VanWagner L.B., Wilcox J.E., Colangelo L.A., et al. Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study. Hepatology 2015, 62(3):773-783. 10.1002/hep.27869.
13. Al Rifai M., Silverman M.G., Nasir K., et al. The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis 2015, 239(2):629-633.
14. Adams L.A., Lymp J.F., St Sauver J., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005, 129:113-121.
15. Rafiq N., Bai C., FangY, et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin. Gastroenterol. Hepatol. 2009, 7:234-238.
16. Soderberg C., Stal P., Askling J., et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 2010, 51:595-602.
17. Nguyen Q.M., Toprak A., Xu J.H., Srinivasan S.R., Chen W., Berenson G.S. Progression of segment-specific carotid artery intima-media thickness in young adults (from the bogalusa heart study). Am. J. Cardiol. 2011, 107:114-119.
18. Tattersall M.C., Gassett A., Korcarz C.E., et al. Predictors of carotid thickness and plaque progression during a decade: the multi-ethnic study of atherosclerosis. Stroke 2014, 45(11):3257-3262.
19. Rosvall M., Persson M., Östling G., et al. Risk factors for the progression of carotid intima-media thickness over a 16-year follow-up period: the Malmö diet and cancer study. Atherosclerosis 2015, 239(2):615-621.
20. Baldassarre D., Hamsten A., Veglia F., et al. Improve study group. Measurements of carotid intima-media thickness and of interadventitia common carotid diameter improve prediction of cardiovascular events: results of the improve (carotid intima media thickness [imt] and imt-progression as predictors of vascular events in a high risk european population) study. J. Am. Coll. Cardiol. 2012, 60(16):1489-1499.
21. Lorenz M.W., Polak J.F., Kavousi M., et al. Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data. Lancet 2012, 379:2053-2062.
22. Inaba Y., Chen J.A., Bergmann S.R. Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artetorry disease events: a meta-analysis. Atherosclerosis 2012, 220:128-133.
23. Wannarong T., Parraga G., Buchanan D., et al. Progression of carotid plaque volume predicts cardiovascular events. Stroke 2013, 44:1859-1865.
24. Fracanzani A.L., Burdick L., Raselli S., et al. Carotid artery intima-media thickness in nonalcoholic fatty liver disease. Am. J. Med. 2008, 121(1):72-78.
25. Norata G.D., Garlaschelli K., Ongari M., et al. Effect of the toll-like receptor 4 (TLR-4) variants on intima-media thickness and monocyte- derived macrophage response to LPS. J. Intern Med. 2005, 258(1):21-27.
26. Third report of the National Cholesterol Education Program Expert Panel on Detection Evaluation and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002, 106:3143-3421.
27. Diabetes ACE/ADA Task Force on Inpatient Diabetes American college of endocrinology and american diabetes association consensus statement on inpatient diabetes and glycemic control. Diabetes Care 2006, 29:1955e62.
28. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an american heart association/national heart, lung, and blood institute scientific statement: executive summary. Crit. Pathw. Cardiol. 2005, 4(4):198-203.
29. Sanford N.L., Walsh P., Matis C., et al. Is ultrasonography useful in the assessment of diffuse parenchymal liver disease?. Gastroenterology 1985, 89:186-191.
30. Hernaez R., Lazo M., Bonekamp S., et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011, 54:1082-1090.
31. Kleiner D.E., Brunt E.M., Van Natta M., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 411:313-321.
32. Mukherjee D., Yadav J.S. Carotid artery intima-media thickness: indicator of atherosclerosis burden and response to risk factor modification. Am. Heart J. 2002, 144:753-759.
33. Stein J.H., Fraiser M.C., Aeschlimann S.E., Nelson-Worel J., McBride P.E., Douglas P.S. Vascular age: integrating carotid intima-media thickness measurements with global coronary risk assessment. Clin. Cardiol. 2004, 27:388-392.
34. Armitage P., Berry G., Matthews J.N.S. Statistical Methods in Medical Research 2002, Blackwell Science, Oxford. fourth ed.
35. Twisk J.W.R. Applied Longitudinal Data Analysis for Epidemiology 2003, Cambridge University Press, Cambridge.
36. Ballestri S., Lonardo A., Bonapace S., Byrne C.D., Loria P., Targher G. Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. World J. Gastroenterol. 2014, 20:1724-1745.
37. Anstee Q.M., Targher G., Day C.P. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat. Rev. Gastroenterol. Hepatol. 2013, 10:330-344.
38. Lorenz M.W., Markus H.S., Bots M.L., Rosvall M., Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007, 115(4):459-467.
39. Polak J.F., Pencina M.J., O'Leary D.H., D'Agostino R.B. Common carotid artery intima-media thickness progression as a predictor of stroke in multi-ethnic study of atherosclerosis. Stroke 2011, 42(11):3017-3021.
40. Herder M., Johnsen S.H., Arntzen K.A., Mathiesen E.B. Risk factors for progression of carotid intima-media thickness and total plaque area: a 13-year follow-up study: the Tromsø Study. Stroke 2012, 43(7):1818-1823.
41. Koskinen J., Kähönen M., Viikari J.S., et al. Conventional cardiovascular risk factors and metabolic syndrome in predicting carotid intima-media thickness progression in young adults: the cardiovascular risk in young finns study. Circulation 2009, 120:229-236.
42. Chambless L.E., Folsom A.R., Davis V., et al. Risk factors for progression of common carotid atherosclerosis: the atherosclerosis risk in communities study, 1987-1998. Am. J. Epidemiol. 2002, 155(1):38-47.
43. Mellinger J.L., Pencina K.M., Massaro J.M., et al. Hepatic steatosis and cardiovascular disease outcomes: an analysis of the framingham heart study. J. Hepatol. 2015, 63:470-476.
44. Dutheil F., Lac G., Lesourd B., Chapier R., et al. Different modalities of exercise to reduce visceral fat mass and cardiovascular risk in metabolic syndrome: the RESOLVE randomized trial. Int. J. Cardiol. 2013, 168(4):3634-3642.
45. Keating S.E., Hackett D.A., George J., Johnson N.A. Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J. Hepatol. 2012, 57(1):157-166.
46. Chen Y., Xu M., Wang T., et al. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease. Atherosclerosis 2015, 241(1):145-150.
47. Targher G., Bertolini L., Padovani R., et al. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006, 29(6):1325-1330.